The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease

Abstract : Alzheimer's disease (AD) is the most common neurodegenerative disorder in elderly people. AD is characterized by a progressive cognitive decline and it is neuropathologically defined by two hallmarks: extracellular deposits of aggregated β-amyloid (Aβ) peptides and intraneuronal fibrillar aggregates of hyper- and abnormally phosphorylated Tau proteins. AD results from multiple genetic and environmental risk factors. Epidemiological studies reported beneficial effects of caffeine, a non-selective adenosine receptors antagonist. In the present review, we discuss the impact of caffeine and of adenosinergic system modulation on AD, in terms of pathology and therapeutics.
Document type :
Journal articles
Complete list of metadatas

Cited literature [120 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-01930487
Contributor : David Blum <>
Submitted on : Thursday, November 22, 2018 - 9:18:00 AM
Last modification on : Thursday, March 7, 2019 - 4:16:05 PM
Long-term archiving on : Saturday, February 23, 2019 - 1:28:14 PM

File

fnins-12-00520.pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Luc Cellai, Kevin Carvalho, Emilie Faivre, Aude Deleau, Didier Vieau, et al.. The Adenosinergic Signaling: A Complex but Promising Therapeutic Target for Alzheimer’s Disease. Frontiers in Neuroscience, Frontiers, 2018, 12, pp.520. ⟨10.3389/fnins.2018.00520⟩. ⟨inserm-01930487⟩

Share

Metrics

Record views

73

Files downloads

126